Home » Topics » Regulatory

Regulatory
RSS

FDA approves tablet formulation of CollaGenex's Periostat

Feb. 6, 2001

Formulation of glibenclamide with excellent percutaneous absorption

Feb. 6, 2001

Orion claims new use for levosimendan

Feb. 6, 2001

E.U. approves Remicade for broader RA indication

Feb. 6, 2001

Compositions and methods of treating obesity claimed by Knoll

Feb. 5, 2001

FDA issues approvable letter for Visudyne

Feb. 5, 2001

FDA approves vagus nerve stimulation trial for anxiety disorders

Feb. 5, 2001

Dimethaid begins mutual recognition procedure in E.U. for Pennsaid

Feb. 2, 2001

Femara receives E.U. approval as first-line breast cancer therapy

Feb. 1, 2001

Caelyx receives approval in Canada for treatment of advanced ovarian cancer

Jan. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...